Article
NF-kB and the CLL microenvironment
30 Mar 2023
Abstract excerpt
Chronic lymphocytic leukemia (CLL) is the most prevalent type of leukemia in the western world. Despite the positive clinical effects of new targeted therapies, CLL still remains an incurable and refractory disease and resistance to treatments are commonly encountered. The Nuclear Factor-Kappa B (NF-κB) transcription factor has been implicated in the pathology of CLL, with high levels of NF-κB associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
